Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer (Q40213644)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 2006
edit
Language Label Description Also known as
English
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer
scientific article published on November 2006

    Statements

    Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer (English)
    Charles N Landen
    Karen T Coffman
    Elizabeth Bruckheimer
    Jyotsnabaran Halder
    Lingegowda S Mangala
    William M Merritt
    Rosemarie Schmandt
    Aparna A Kamat
    Gary E Gallick

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit